KR20210002875A - Cosmetic composition for anti-inflametion, anti-wrinkle, whitening and anti-bacterial comprising Extract of Chrysanthemum morifolium - Google Patents

Cosmetic composition for anti-inflametion, anti-wrinkle, whitening and anti-bacterial comprising Extract of Chrysanthemum morifolium Download PDF

Info

Publication number
KR20210002875A
KR20210002875A KR1020190078692A KR20190078692A KR20210002875A KR 20210002875 A KR20210002875 A KR 20210002875A KR 1020190078692 A KR1020190078692 A KR 1020190078692A KR 20190078692 A KR20190078692 A KR 20190078692A KR 20210002875 A KR20210002875 A KR 20210002875A
Authority
KR
South Korea
Prior art keywords
jeju
udo
chrysanthemum
cosmetic composition
wrinkle
Prior art date
Application number
KR1020190078692A
Other languages
Korean (ko)
Other versions
KR102242755B1 (en
Inventor
안명근
Original Assignee
안명근
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 안명근 filed Critical 안명근
Priority to KR1020190078692A priority Critical patent/KR102242755B1/en
Publication of KR20210002875A publication Critical patent/KR20210002875A/en
Application granted granted Critical
Publication of KR102242755B1 publication Critical patent/KR102242755B1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005Antimicrobial preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/82Preparation or application process involves sonication or ultrasonication

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Cosmetics (AREA)

Abstract

The present invention relates to an organic solvent extract from Chrysanthemum morifolium RAMAT. of Udo island in Jeju and to an anti-inflammatory, anti-wrinkle, whitening and anti-bacterial functional cosmetic composition comprising the same as an active ingredient.

Description

제주 우도 국화꽃 추출물을 포함하는 피부 항염, 항주름, 미백 및 항균 기능성 화장료 조성물{Cosmetic composition for anti-inflametion, anti-wrinkle, whitening and anti-bacterial comprising Extract of Chrysanthemum morifolium}Cosmetic composition for anti-inflametion, anti-wrinkle, whitening and anti-bacterial comprising Extract of Chrysanthemum morifolium}

본 발명은 제주 우도 국화꽃 추출물을 유효성분으로 함유하는 피부 항염, 항주름 및 항균 기능성 화장용 조성물에 관한 것이다.The present invention relates to a skin anti-inflammatory, anti-wrinkle and antibacterial functional cosmetic composition containing Jeju Udo chrysanthemum flower extract as an active ingredient.

지금까지 국화과 식물의 항산화활성, 미백, 항염증활성에 관한 연구는 다수 공지되어 있으나 제주 우도 국화꽃의 인체 피부 항염, 항주름, 미백 및 항균 활성에 대항 연구는 이루어진 바 없다.Until now, a number of studies on the antioxidant activity, whitening, and anti-inflammatory activity of Asteraceae plants have been known, but no studies have been conducted on the anti-inflammatory, anti-wrinkle, whitening and antibacterial activities of the chrysanthemum flowers in Jeju Udo.

국화(Chrysanthemum morifolium RAMAT.)는 국화목 국화과에 속하는 여러해살이 식물로 중국이 원산으로 알려져 있으며 우리나라에는 중부 이남지역의 산간지에 널리 자생되고 있다. 국화의 다른 이름은 감국화(甘菊花)·절화(節華)·일정(日精)·주영(周盈)·부연년(傅延年)·여절(女節)·여경(女莖)·갱생(更生)·음성(陰城)이다. Chrysanthemum ( Chrysanthemum morifolium RAMAT.) is a perennial plant belonging to the Chrysanthemum family Asteraceae. It is known to be native to China, and is widely grown in mountainous areas in the south central region of Korea. Other names for chrysanthemum are Gamgukhwa (甘菊花), Jeolhwa (節華), Iljeong (日精), Jooyoung (周盈), Buyeonyeon (傅延年), Yeojeol (女節), Yeokyung (女莖), and rehabilitation (更生). )·Eumseong(陰城).

또 국화는 성질이 평(平)하고 맛이 달며 독이 없어 장위를 편안하게 하고 5맥을 좋게 하며 팔다리를 잘 놀리게 하고 풍으로 어지러운 것과 두통에 쓰인다. 또 눈의 정혈을 돕고 눈물이 나는것을 멈추며 머리와 눈을 시원하게 하고 풍습비(風濕痺)를 치료하는 약초로 알려져 있다.In addition, chrysanthemum has a flat nature, has a sweet taste, and has no poison, so it comforts the long-term, improves the five veins, makes limbs well, and is used for dizziness and headaches. In addition, it is known as a medicinal herb that helps blood congestion in the eyes, stops tears, cools the head and eyes, and treats wind and rain.

특히 해열 작용, 혈압 강하 작용, 심혈관 확장 작용 등이 실험에서 밝혀졌다. In particular, the antipyretic action, blood pressure lowering action, and cardiovascular dilatation action were found in experiments.

국화에는 주로 정유, 플라보노이드, 세스퀴테르페노이드, 트리테르페노이드 등의 성분이 알려져 있다.In chrysanthemum, ingredients such as essential oils, flavonoids, sesquiterpenoids, and triterpenoids are known.

국화의 물 추출물 및 플라보노이드에는 뚜렷한 항산화 활성이 알려져 있다. 인체세포의 유리기에 대한 제거작용을 증강할 수 있으며 노화를 억제시킬 수 있다고 알려져 있다.Chrysanthemum water extract and flavonoids are known for their distinct antioxidant activity. It is known that it can enhance the removal of free radicals in human cells and inhibit aging.

피부노화는 크게 두 가지로 나뉘어 연구되고 있으며, 그 중 하나는 '내적노화'로써 연령의 증가에 따른 노화현상이고 다른 하나는 '외적노화'로써 외부환경 즉 자외선이나 공해 등으로 인한 노화현상을 말한다. 피부노화에 관하여서는 지금까지 여러 이론이 제시되고 있으나 그 중 피부 노화에 가장 과학적으로 접근된 이론은 산화에 의한 피부노화 이론이다. Skin aging is largely divided into two studies, one of which is'internal aging', which is an aging phenomenon with increasing age, and the other is'external aging', which refers to an aging phenomenon caused by external environment, such as ultraviolet rays or pollution. . There have been several theories on skin aging so far, but among them, the most scientifically approached theory for skin aging is the skin aging theory due to oxidation.

산화에 의한 피부 노화는 자유 라디칼(free radical)에 기인한 것으로서, 자유 라디칼 이론은 1950년대 중반 디하만(D. Harman)에 의해서 제시되었다. 자유 라디칼은 백혈구의 식작용, 미토콘드리아에서의 ATP 생산과정 중 전자 전달계, 미엘로퍼 옥사이드(Myeloper Oxide(MPO))의 작용, 자외선, 담배, 정상적인 대사 과정, 스트레스, 공해 물질, 세균에 의해 생성되며, 이러한 원인에 의해 라디칼이 인체에 잔류하게 되는 경우 체내에서 세포의 파괴, 결합 조직의 절단, 교차 결합 유도 등을 통하여 주름형성, 피부암, 세포 살상, 류마티스성 관절염, 아토피성 피부염, 여드름 등 여러 가지 문제를 발생시킨다. 인체에는 천연 항산화물질(라디칼 소거제)인 슈퍼옥사이드 디스뮤타제 (SuperOxide Dismatase:SOD), 카탈라아제, 비타민 E, 비타민 C, 유비퀴놀 (Uviquinol) 등이 존재하여 자유 라디칼을 제거할 수 있지만, 이러한 체내 항산화 체계는 나이, 공해, 자외선, 스트레스 등에 의해 점차적으로 그 기능이 쇠퇴하기 시작하여 항산화 체계가 무력화 되고, 이는 결국 체내 자유라디칼의 증가로 이어진다. 증가된 라디칼은 진피의 결합조직인 콜라겐(Collagen), 엘라스틴 (Elastin), 히아루론산(Hyaluronic aicd) 등을 파괴하여 피부 침하 현상(주름)을 일으키고, 세포막의 지질 부분을 산화시켜 세포를 파괴함으로써 피부염, 여드름, 피부암 등의 질병을 유발한다. 또한 이 라디칼은 멜라닌 형성과정 중 자발적 산화반응에 관여하여 기미, 주근깨 등의 원인 및 주름생성의 원인이 되기도 한다(대한 화장품학회지 23권 1호 75~132).Skin aging due to oxidation is due to free radicals, and the free radical theory was proposed by D. Harman in the mid-1950s. Free radicals are produced by the phagocytosis of leukocytes, the electron transport system in the process of ATP production in mitochondria, the action of myeloper oxide (MPO), ultraviolet rays, cigarettes, normal metabolic processes, stress, pollutants, and bacteria. When radicals remain in the human body due to a cause, various problems such as wrinkle formation, skin cancer, cell killing, rheumatoid arthritis, atopic dermatitis, acne, etc. can be solved through destruction of cells, cutting of connective tissue, and induction of cross-linking. Occurs. In the human body, natural antioxidants (radical scavengers) such as SuperOxide Dismatase (SOD), catalase, vitamin E, vitamin C, and ubiquinol are present and can remove free radicals. The antioxidant system gradually begins to decline due to age, pollution, ultraviolet rays, and stress, and the antioxidant system becomes incapacitated, which in turn leads to an increase in free radicals in the body. Increased radicals destroy the connective tissues of the dermis, such as collagen, elastin, hyaluronic acid, etc., causing skin subsidence (wrinkles), and oxidizing the lipid part of the cell membrane to destroy cells, resulting in dermatitis and acne. , Cause skin cancer and other diseases. In addition, this radical is involved in the spontaneous oxidation reaction during the melanin formation process, causing spots, freckles, and wrinkles (Journal of the Korean Cosmetics Association, Volume 23, No. 1, 75-132).

알러지(allergy)는 처음 항원이 체내에 유입되었을 때 해당 항원에 반응하는 항체가 생긴 후, 다시 동일한 물질이 체내에 들어오는 경우 항원-항체 반응을 일으키는 현상으로서, 과민증, 재채기, 두드러기 등의 증상이 나타난다. 일반인에게는 상기 항원이 아무런 문제를 일으키지 않으나, 특정인에게 있어서 과민반응을 일으키는 것으로서, 알러지를 일으키는 원인 물질인 알러젠(allergen)이 항원으로 체내에 침입하게 되면, 해당 알러젠에 대한 항체(IgE)가 생성되어 조직 내 비만세포(mast cell)에 부착되어 있다가, 원인 알러젠이 재 침입하는 경우 비만 세포의 IgE와 결합하여 비만세포가 탈과립(Degranulation)화 하면서 히스타민(histamine), 세로토닌(serotonin), 레닌(renin) 등 여러 가지 물질이 유리되어 재채기, 소양감 등이 나타나게 된다.Allergy is a phenomenon that causes an antigen-antibody reaction when an antibody that reacts to the antigen is generated when an antigen is first introduced into the body, and then the same substance enters the body again. Symptoms such as hypersensitivity, sneezing, and hives appear. . The antigen does not cause any problems in the general population, but it causes hypersensitivity in a specific person, and when allergen, a substance causing allergy, enters the body with the antigen, an antibody (IgE) against the allergen is produced. When the allergen is attached to the mast cell in the tissue and the causative allergen re-invades, it binds to the IgE of the mast cell and degranulates the mast cell, resulting in histamine, serotonin, and renin. ), etc., are released, causing sneezing and itching.

최근 환경오염물질의 증가, 식생활의 변화, 각종 스트레스 등으로 인한 알러지(Allergy)성 질환이 증가하고 있으며 2000년대에 들어 전체인구의 약 5% 이상이 알러지 질환 환자인 것으로 보고되고 있다. 또한 이물질(Allergen 또는 Antigen)에 대해 특이적 변형 반응을 나타내는 생화학적 현상인 알러지는 비만세포 등에서 일어나는 탈과립 현상에 의해 나타나는데, 탈과립은 Fc 수용체에 대한 항원, anti-IgE, 렉틴 등의 결합과 칼슘 증가에 기인한다. 최근 들어 알러지성 질환의 원인이 점차적으로 밝혀지고 있으나,아직까지 알러지 질환을 완치할 수 있는 약물은 개발되고 있지 못하며, 다만 증상개선의 효과만을 기대하고 있는 실정이다.Allergy-related diseases due to the recent increase in environmental pollutants, changes in diet, and various stresses are on the rise, and it is reported that more than 5% of the total population are allergic disease patients in the 2000s. In addition, allergy, which is a biochemical phenomenon that exhibits a specific transformation reaction to foreign substances (Allergen or Antigen), is caused by degranulation that occurs in mast cells, etc. Degranulation is caused by binding of antigens to Fc receptors, anti-IgE, lectins, etc. and increasing calcium. Caused by Recently, the cause of allergic diseases has been gradually identified, but drugs that can cure allergic diseases have not yet been developed, but only the effect of improving symptoms is expected.

이처럼 산화반응 또는 알러지성 염증반응에 대해 특별한 치료 방법이 없는 상황에서, 보다 효과적인 조성물을 발견하고자 본 발명자들이 예의 노력한 결과, 제주 우도 국화꽃 추출물이 항산화 및 염증 질환을 예방 또는 치료하는 용도로 유용함을 밝혀내는 한편, 미백 및 항균 기능성 화장료 조성물로도 뛰어난 효과가 있음을 밝혀내고, 이를 효과적으로 추출하기 위한 방법으로 초음파 추출 방법을 개발하여 본 발명을 완성하기에 이르렀다.As a result of the present inventors' diligent efforts to find a more effective composition in a situation where there is no special treatment method for oxidation or allergic inflammatory reactions, Jeju Udo chrysanthemum flower extract is useful for preventing or treating antioxidant and inflammatory diseases. On the other hand, it was found that the whitening and antibacterial functional cosmetic composition has excellent effects, and the present invention was completed by developing an ultrasonic extraction method as a method for effectively extracting it.

대한민국 등록특허공보 제 10-278203호Korean Patent Publication No. 10-278203 대한민국 공개특허공보 제 10-2009-0042450호Korean Patent Application Publication No. 10-2009-0042450 대한민국 공개특허공보 제 10-2017-0100076호Republic of Korea Patent Publication No. 10-2017-0100076 대한민국 공개특허공보 제 10-2006-0108864호Korean Patent Application Publication No. 10-2006-0108864

EL-Domyati M et.al., Exp Dermatololl, 2002EL-Domyati M et.al., Exp Dermatololl, 2002 Serafin, WE, In Goodman and Gillmans, The Pharmacological Basis of Therapeutics, Hardmen, Ja; Limbird, L,E eds, Mc Graw-Hill, Newyork, 1996, 659-682Serafin, WE, In Goodman and Gillmans, The Pharmacological Basis of Therapeutics, Hardmen, Ja; Limbird, L,E eds, Mc Graw-Hill, Newyork, 1996, 659-682 Townley RG & 0kada, C, Annals of Allergy, 68, 1991, 190-196Townley RG & 0kada, C, Annals of Allergy, 68, 1991, 190-196 korean J. plant Res., 23(1):47, 2010korean J. plant Res., 23(1):47, 2010

따라서, 발명의 목적은 제주 우도 국화꽃 추출물 및 이를 유효성분으로 함유하는 화장료 조성물을 제공하는 데 있다.Accordingly, an object of the present invention is to provide a Jeju Udo chrysanthemum flower extract and a cosmetic composition containing the same as an active ingredient.

본 발명의 다른 목적은 상기 제주 우도 국화꽃 추출물의 제조방법과 상기 방법에 따라 제조된 국화꽃 추출물을 유효성분으로 하는 피부의 항염, 항주름, 미백 및 항균 기능성 화장료 조성물을 제공하는 데 있다.Another object of the present invention is to provide an anti-inflammatory, anti-wrinkle, whitening and antibacterial functional cosmetic composition for skin using the method for preparing the Jeju Udo chrysanthemum flower extract and the chrysanthemum flower extract prepared according to the method as an active ingredient.

본 발명의 상기 목적은 제주 우도 국화꽃(Chrysanthemum Morifolium)의 추출물을 제조하는 단계와; 상기 단계에서 얻은 제주 우도 국화꽃 추출물을 막필터(membrane filter)를 사용하여 여과를 수행하는 단계로 이루어지며 상기 단계에서 수득한 제주 우도 국화꽃 추출물의 항염, 항주름, 미백 및 항균 활성을 평가함으로써 달성하였다.The object of the present invention is to prepare an extract of Jeju Udo chrysanthemum flower (Chrysanthemum Morifolium); It consists of filtering the Jeju Udo chrysanthemum flower extract obtained in the above step using a membrane filter, and by evaluating the anti-inflammatory, anti-wrinkle, whitening and antibacterial activity of the Jeju Udo chrysanthemum flower extract obtained in the above step. Achieved.

본 발명에 따르면 신규 제주 우도 국화꽃 추출물을 제공하는 효과가 있고 이를 유효성분으로 함유하는 항염, 항주름, 미백 및 항균 활성의 우수한 신규한 화장료 조성물과 다양한 제형의 화장품을 제공할 수 있는 뛰어난 효과가 있다.According to the present invention, there is an effect of providing a new Jeju Udo chrysanthemum flower extract, and a novel cosmetic composition with excellent anti-inflammatory, anti-wrinkle, whitening and antibacterial activity containing it as an active ingredient, and excellent effect of providing cosmetics of various formulations. have.

도 1은 본 발명에 따른 제주 우도 국화꽃 추출물의 항염 효과의 실험결과를 나타낸 그래프이다.
도 2는 본 발명에 따른 제주 우도 국화꽃 추출물의 항주름 효과의 실험결과를 나타낸 그래프이다.
도 3은 본 발명에 따른 제주 우도 국화꽃 추출물의 미백 효과의 실험결과를 나타낸 그래프이다.
도 4는 본 발명에 따른 제주 우도 국화꽃 추출물의 항산화 효과의 실험결과를 나타낸 그래프이다.
도 5는 본 발명에 따른 공시재료로 사용한 제주 우도 국화꽃 식물의 사진도이다.
1 is a graph showing the experimental results of the anti-inflammatory effect of the Jeju Udo chrysanthemum flower extract according to the present invention.
2 is a graph showing the experimental results of the anti-wrinkle effect of the Jeju Udo chrysanthemum flower extract according to the present invention.
3 is a graph showing the experimental results of the whitening effect of the Jeju Udo chrysanthemum flower extract according to the present invention.
4 is a graph showing the experimental results of the antioxidant effect of the Jeju Udo chrysanthemum flower extract according to the present invention.
5 is a photographic view of a chrysanthemum flower plant in Jeju Udo used as a test material according to the present invention.

이하, 본 발명을 실시예의 양태에 따라 상세히 설명한다. 하기 실시예는 본 발명을 예시할 뿐 본 발명의 권리범위가 하기 실시예에 제한되는 것은 아니다.Hereinafter, the present invention will be described in detail according to embodiments of the present invention. The following examples only illustrate the present invention, but the scope of the present invention is not limited to the following examples.

본 발명 제주 우도 국화꽃 추출물의 제조Preparation of the present invention Jeju Udo chrysanthemum flower extract

건조된 제주우도국화꽃 4~5g에 40% 부틸렌글리콜(butylene glycol) 40∼60 mL를 첨가한 후 solificator(JAC 4020, Jinwoo, Korea)를 이용하여 온도를 40℃로 고정한 후 추출하였다. 이렇게 추출된 시료는 0.45㎛ 막 필터로 여과를 수행하여 본 발명 제주우도국화꽃 추출물을 얻었다. 모든 과정은 1시간씩 3회 반복하여 실시하였다.After adding 40 to 60 mL of 40% butylene glycol to 4 to 5 g of dried Jeju Udo chrysanthemum flowers, extraction was performed after fixing the temperature at 40°C using a solificator (JAC 4020, Jinwoo, Korea). The sample thus extracted was filtered through a 0.45 μm membrane filter to obtain the Jeju Udo chrysanthemum flower extract of the present invention. All processes were repeated 3 times for 1 hour.

상기 방법으로 제조된 제주 우도 국화꽃 추출물은 수득 후 40℃에서 냉장보관하고 실험에 제공하였다.After obtaining the Jeju Udo chrysanthemum flower extract prepared by the above method, it was refrigerated at 40°C and provided for the experiment.

본 발명에 따른 용매추출과정에서 사용한 용매의 종류 및 초음파 처리조건에 따른 제주 우도 국화꽃 추출물의 수득량은 하기와 같다(표 1).The yield of Jeju Udo chrysanthemum flower extract according to the type of solvent and ultrasonic treatment conditions used in the solvent extraction process according to the present invention is as follows (Table 1).

구분division 사용 용매Solvent used 수득량(g)
(0.45㎛ 멤브레인필터 여과)
Yield (g)
(0.45㎛ membrane filter filtration)
Solificator 초음파키(40.5KHz)Solificator ultrasonic key (40.5KHz)
실시예 1Example 1 70%
1,3-부틸렌글리콜
70%
1,3-butylene glycol
125.4125.4 초기 250w(40℃)/
후기 500w(40℃)/1hr
Initial 250w (40℃)/
Late 500w(40℃)/1hr
비교예 1Comparative Example 1 water 84.384.3 상동Homology 비교예 2Comparative Example 2 30% 에탄올30% ethanol 96.796.7 상동Homology 비교예Comparative example 70% 에탄올70% ethanol 101.1101.1 상동Homology

상기 처리 용매 및 조건에서 부유물이 없는 이상적인 추출물을 얻을 수 있었다.In the above treatment solvent and conditions, an ideal extract without suspension could be obtained.

제주 우도 국화꽃 추출물의 기능성 효능실험Functional efficacy test of Jeju Udo chrysanthemum flower extract

실험예 2-1. 본 발명 제주 우도 국화꽃 추출물의 항염효과Experimental Example 2-1. Anti-inflammatory effect of the present invention Jeju Udo chrysanthemum flower extract

Mouse macrophage cell인 RAW 264.7 cell에 염증 유발물질인 LPS(Lipopolysaccharide)를 인위적으로 처리한 후 염증 억제 효과가 있는지를 평가하였다. 96 well plate에 well 당 2×105 cell이 되도록 분주한 다음, 24시간 동안 37℃, 5% CO2 incubator에서 배양하였다. Overnight하고 새로운 배지로 교환한 후 LPS(1ug/mL)와 추출물을 농도별로 투여하여 24시간 동안 배양하였다. 배양 후, 배지 상층액을 취해 13,000 rpm에서 3분 동안 원심 분리하여 상등액만 모아서 Griess 시약과 1:1로 반응시키고 570nm에서 흡광도를 측정하였다.The mouse macrophage cells, RAW 264.7 cells, were artificially treated with LPS (Lipopolysaccharide), a substance that induces inflammation, and then we evaluated whether they had an inhibitory effect on inflammation. After dispensing to a 96 well plate to a size of 2×10 5 cells per well, it was incubated in a 37°C, 5% CO2 incubator for 24 hours. After overnight and exchange with a new medium, LPS (1 ug/mL) and extract were administered by concentration and cultured for 24 hours. After incubation, the supernatant of the medium was taken and centrifuged at 13,000 rpm for 3 minutes, only the supernatant was collected, reacted 1:1 with Griess reagent, and absorbance was measured at 570 nm.

실험결과, 제주 우도 국화꽃 추출물은 농도에 따라 NO 생성을 효과적으로 억제하였으며, 2%처리 시 69.1%의 뛰어난 NO 저해능을 나타내었다(도 1).As a result of the experiment, Jeju Udo chrysanthemum flower extract effectively inhibited NO generation depending on the concentration, and showed excellent NO inhibition ability of 69.1% when treated with 2% (Fig. 1).

실험예 2-2. 본 발명 제주 우도 국화꽃 추출물의 항주름 실험Experimental Example 2-2. Anti-wrinkle test of the present invention Jeju Udo chrysanthemum flower extract

피부 섬유아세포(HDFn)를 48 well 플레이트에 5×104 cells/well의 농도로 배양 배지 0.3 mL로 접종하여 37℃, 5% CO2에서 배양하였다. 24시간 지난 이후 추출물을 농도별로 포함한 새로운 배지로 24시간 동안 배양하였다. 24시간 배양 이후 배양액을 모아서 enzymes-linked immunoassay kit (Takara사)를 이용하여 콜라겐 전구체의 C-말단의 양을 측정하였다. 또한, 콜라겐 용액 640 ng/mL을 이용하여 콜라겐 농도 0 ng-640 ng 사이의 standard curve를 얻어 배지에 있는 콜라겐 양을 계산하였다.Skin fibroblasts (HDFn) were inoculated with 0.3 mL of culture medium at a concentration of 5×10 4 cells/well in a 48 well plate and cultured at 37°C and 5% CO2. After 24 hours, the extract was cultured for 24 hours in a new medium containing each concentration. After culturing for 24 hours, the culture medium was collected and the amount of the C-terminus of the collagen precursor was measured using an enzymes-linked immunoassay kit (Takara). In addition, a standard curve between 0 ng-640 ng of collagen concentration was obtained using 640 ng/mL of collagen solution, and the amount of collagen in the medium was calculated.

실험결과, 제주 우도 국화꽃 추출물은 농도의 존적으로 콜라겐 합성이 증가하는 효과를 나타내었고, 2% 첨가 시 23%의 콜라겐 합성능을 나타내었다(도 2).As a result of the experiment, Jeju Udo chrysanthemum flower extract showed an effect of increasing collagen synthesis depending on the concentration, and when 2% was added, it showed 23% collagen synthesis ability (FIG. 2).

실험예 2-3. 본 발명 제주 우도 국화꽃 추출물의 항균효과Experimental Example 2-3. Antibacterial Effects of the Invention Jeju Udo Chrysanthemum Flower Extract

[실험방법] [Experiment method]

1. 시험균주1. Test strain

Staphylococcus aureus : LB ager plate에서 37℃ Х 24시간 배양 후 single colony를 취하여 LB 액체배지에 접종 후 30℃ shaking incubator에서 18시간 배양 시킨 후 사용하였다. (균수 109 cfu/ml정도)Staphylococcus aureus: After incubating for 24 hours at 37℃ on an LB ager plate, a single colony was taken, inoculated in LB liquid medium, and incubated for 18 hours in a shaking incubator at 30℃. (Number of bacteria around 10 9 cfu/ml)

Escherichia coli : LB agar plate에서 37℃ Х 24시간 배양 후 single colony를 취하여 LB 액체배지에 접종 후 30℃ shaking incubator에서 18시간 배양 시킨 후 사용하였다. (균수 109 cfu/ml정도)Escherichia coli: After incubating for 24 hours at 37°C on an LB agar plate, a single colony was taken, inoculated in LB liquid medium, and incubated for 18 hours in a shaking incubator at 30°C. (Number of bacteria around 10 9 cfu/ml)

Candida albicans : YM agar plate에서 30℃ Х 24시간 배양 후 single colony를 취하여 YM 액체배지에 접종 후 30℃ shaking incubator에서 18시간 배양 시킨 후 사용하였다. (균수 109 cfu/ml정도)Candida albicans: After incubation at 30℃ for 24 hours on a YM agar plate, a single colony was taken, inoculated in YM liquid medium, and incubated for 18 hours in a 30℃ shaking incubator. (Number of bacteria around 10 9 cfu/ml)

2. 제주 우도 국화꽃 추출물을 100%, 50%, 25%, 12.5%, 6.2%의 농도와 positive control인 Tetracycline(50μg/ml, 12.5 μg/ml), Ketoconazole 0.25% 그리고 각각의 균주를 104 만큼 well 에 넣어준 후 shaking incubator에서 30℃, 20시간 배양 후 흡광도 600에서 측정하여 측정값을 저해활성으로 환산하여 계산하였다.2. Concentration of 100%, 50%, 25%, 12.5%, 6.2% of Jeju Udo chrysanthemum flower extract and positive control Tetracycline (50μg/ml, 12.5 μg/ml), Ketoconazole 0.25% and each strain as much as 104 After putting it in the well, it was incubated at 30°C for 20 hours in a shaking incubator and measured at absorbance 600, and the measured value was converted into inhibitory activity.

실험결과, 대장균(E. coli), 피부상재균(C. albicans)에서 농도의 존적으로 항균 활성을 나타냈다(표 2).As a result of the experiment, E. coli and C. albicans showed antibacterial activity in a concentration-dependent manner (Table 2).

Figure pat00001
Figure pat00001

2-4. 본 발명 제주 우도 국화꽃 추출물의 미백 효과 실험2-4. Whitening effect experiment of the present invention Jeju Udo chrysanthemum flower extract

murine melanoma(B16 F1) 세포를 적량의 FBS(fetal bovine serum)가 함유된 DMEM 배지로 24 well plate에 well 당 적정량의 세포를 접종한 후 5% CO2, 37℃에서 24시간 배양하였다. 상기 배양액의 배지를 제거하고 시료를 적당한 농도로 희석된 배지로 교체한 후 5% CO2, 37℃에서 72시간 다시 배양하였다. 배양 후 배양액의 배지를 제거하고 상기에서 얻은 세포 pelle는 60℃에서 건조한 후 10% DMSO가 함유된 1 M 수산화나트륨액을 넣어 60℃ 항온조에서 세포내 멜라닌을 얻었다. 상기에서 얻은 멜라닌을 함유한 반응액을 microplate reader로 405 nm에서 흡광도를 측정하여 세포 수 당 멜라닌 양 또는 일정 단백질 당 멜라닌 양을 측정하였다.The murine melanoma (B16 F1) cells were inoculated with an appropriate amount of cells per well in a 24 well plate with DMEM medium containing an appropriate amount of FBS (fetal bovine serum), and cultured at 37°C for 24 hours at 5% CO2. The medium of the culture medium was removed, the sample was replaced with a medium diluted to an appropriate concentration, and cultured again at 37°C for 72 hours at 5% CO2. After cultivation, the culture medium was removed, and the cell pelle obtained above was dried at 60° C., and then 1 M sodium hydroxide solution containing 10% DMSO was added to obtain intracellular melanin in a 60° C. thermostat. The absorbance of the reaction solution containing melanin obtained above was measured at 405 nm with a microplate reader to measure the amount of melanin per cell number or the amount of melanin per certain protein.

실험 결과, 제주우도국화꽃추출물의 2% 처리하였을 때, melanin 생성을 21.7% 억제하는 효능을 확인하였다(도 3).As a result of the experiment, when 2% of Jeju Udo chrysanthemum flower extract was treated, the effect of inhibiting melanin production by 21.7% was confirmed (FIG. 3).

2-5. 본 발명 제주 우도 국화꽃 추출물의 항산화 효과 실험2-5. Antioxidant effect experiment of the present invention Jeju Udo chrysanthemum flower extract

활성산소에 의한 피부노화 과정은 지질 과산화, 단백질 산화, DNA 산화, 멜라닌 생성, 결합조직의 절단 및 비정상적인 교차결합들을 포함한다. 이들 반응들은 거의 대부분 라디칼 반응으로 자동산화반응 과정이 포함된다. 생체 내에서 자동산화반응을 차단시키는 역할은 항산화제가 담당하고 있다. 전자를 주는 능력 즉, 환원력이 클수록 강한 항산화제가 된다. 항산화제의 환원력을 측정할 수 있는 시약으로 2,2-Diphenyl-1-picrylhydrazyl (DPPH)가 있다. DPPH의 최대 흡수 파장은 517 nm이며, 분자 내 라디칼을 함유하여 방향족 화합물 및 아민류에 의해 라디칼이 소거되어 짙은 자색이 탈색된다. 0.2 mM DPPH 메탄올 용액 100μL에 여러 농도의 시료용액 100μL를 첨가하고 섞은 다음 20 분간 실온반응 시킨 후 517nm 에서 흡광도의 감소정도를 측정한다. 시료의 환원력의 크기는 라디칼 소거능 (scavenging concentration, SC50)으로 표시하며 , SC50 은 DPPH의 농도가 50% 감소하는데 필요한 시료의 농도로 나타낸다. 양성 대조군으로는 Ascorbic acid를 사용하였다.Skin aging processes by free radicals include lipid peroxidation, protein oxidation, DNA oxidation, melanogenesis, cleavage of connective tissue and abnormal crosslinking. Most of these reactions are radical reactions and include automatic oxidation processes. Antioxidants are responsible for blocking the automatic oxidation reaction in vivo. The greater the ability to give electrons, that is, the reducing power, the stronger the antioxidant. 2,2-Diphenyl-1-picrylhydrazyl (DPPH) is a reagent that can measure the reducing power of antioxidants. The maximum absorption wavelength of DPPH is 517 nm, and the radicals are scavenged by aromatic compounds and amines as they contain radicals in the molecule, resulting in decolorization of deep purple. Add 100 μL of sample solution of various concentrations to 100 μL of 0.2 mM DPPH methanol solution, mix, react at room temperature for 20 minutes, and measure the degree of decrease in absorbance at 517 nm. The magnitude of the reducing power of the sample is expressed as the radical scavenging concentration (SC50), and SC 50 is the concentration of the sample required to reduce the DPPH concentration by 50%. Ascorbic acid was used as a positive control.

실험 결과, 제주 우도 국화꽃 추출물은 1.3% (v/v)에서 SC50 (50% Scavenging concentration) value 나타냈으며, 농도-의존적(Dose-dependent) 증가에 따라 항산화 효능을 확인하였다(도 4).As a result of the experiment, the Jeju Udo chrysanthemum flower extract showed an SC 50 (50% Scavenging concentration) value at 1.3% (v/v), and the antioxidant efficacy was confirmed according to a dose-dependent increase (FIG. 4).

본 발명 제주 우도 국화꽃 추출물을 유효성분으로 함유하는 화장료 제형제조 이하에서는 본 발명에 따른 제주 우도 국화꽃 추출물이 함유된 화장료 제제예를 설명하지만 본 발명제품이 이에 한정되지 않는다.Preparation of a cosmetic formulation containing the Jeju Udo chrysanthemum flower extract as an active ingredient of the present invention Hereinafter, an example of a cosmetic formulation containing the Jeju Udo chrysanthemum flower extract according to the present invention will be described, but the present invention is not limited thereto.

3-1. 항염용 에센스 제조(중량%)3-1. Anti-inflammatory essence manufacturing (% by weight)

Figure pat00002
Figure pat00002

3-2. 항주름용 크림(중량%)3-2. Anti-wrinkle cream (wt%)

Figure pat00003
Figure pat00003

3-3. 항균용 클렌징(중량%)3-3. Antibacterial cleansing (% by weight)

Figure pat00004
Figure pat00004

Claims (3)

건조한 제주 우도 국화꽃(Chrysanthemum Morifolium)에 대하여 5~15배의 70% 1,3-부틸렌글리콜을 첨가하고 40.5KHz 초음파기에서 초기 및 후기 250~500w 40℃에서 1시간 추출하여서 된 제주 우도 국화꽃 추출물 Jeju Udo Chrysanthemum flowers made by adding 5 to 15 times 70% 1,3-butylene glycol to the dried Jeju Udo Chrysanthemum (Chrysanthemum Morifolium) and extracting for 1 hour at 250 to 500w 40℃ in the early and late stages with a 40.5KHz ultrasonicator extract 제1항의 제주 우도 국화꽃 추출물을 유효성분으로 함유하는 항염, 항주름, 미백 및 항균 기능성 화장료 조성물Anti-inflammatory, anti-wrinkle, whitening and antibacterial functional cosmetic composition containing the Jeju Udo chrysanthemum flower extract of claim 1 as an active ingredient 제2항에 있어서, 상기 화장료 조성물이 에센서, 크림, 로션, 클렌징, 페이스트 중에서 선택되는 어느 하나의 제형인 것이 특징인 화장료 조성물

The cosmetic composition of claim 2, wherein the cosmetic composition is any one formulation selected from an essensor, cream, lotion, cleansing, and paste.

KR1020190078692A 2019-07-01 2019-07-01 Cosmetic composition for anti-inflametion, anti-wrinkle, whitening and anti-bacterial comprising Extract of Chrysanthemum morifolium KR102242755B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020190078692A KR102242755B1 (en) 2019-07-01 2019-07-01 Cosmetic composition for anti-inflametion, anti-wrinkle, whitening and anti-bacterial comprising Extract of Chrysanthemum morifolium

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020190078692A KR102242755B1 (en) 2019-07-01 2019-07-01 Cosmetic composition for anti-inflametion, anti-wrinkle, whitening and anti-bacterial comprising Extract of Chrysanthemum morifolium

Publications (2)

Publication Number Publication Date
KR20210002875A true KR20210002875A (en) 2021-01-11
KR102242755B1 KR102242755B1 (en) 2021-04-20

Family

ID=74129165

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020190078692A KR102242755B1 (en) 2019-07-01 2019-07-01 Cosmetic composition for anti-inflametion, anti-wrinkle, whitening and anti-bacterial comprising Extract of Chrysanthemum morifolium

Country Status (1)

Country Link
KR (1) KR102242755B1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102550348B1 (en) * 2021-08-06 2023-07-03 주식회사 케이프로텍 Antimicrobial composition comprising fermented product of Chrysanthemum extract by lactic acid bacteria as effective component

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100278203B1 (en) 1998-02-24 2001-01-15 유병팔 Functional stress relief drink using chrysanthemum extract
KR20060108864A (en) 2005-04-14 2006-10-18 인하대학교 산학협력단 Extract of chrysanthemum morifolium ramat, the preparation method thereof and the cosmetic composition comprising the same for whitening
KR20090042450A (en) 2007-10-26 2009-04-30 (주)아모레퍼시픽 Method for preparing chrysanthemum green tea
KR20100033573A (en) * 2008-09-22 2010-03-31 성균관대학교산학협력단 The composition for anti-oxidation or anti-inflammation comprising chrysanthemum extract and the method of preparation thereof
KR20170100076A (en) 2016-02-24 2017-09-04 신성대학 산학협력단 Cosmetic composition comprising aged chrysanthemum

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100278203B1 (en) 1998-02-24 2001-01-15 유병팔 Functional stress relief drink using chrysanthemum extract
KR20060108864A (en) 2005-04-14 2006-10-18 인하대학교 산학협력단 Extract of chrysanthemum morifolium ramat, the preparation method thereof and the cosmetic composition comprising the same for whitening
KR20090042450A (en) 2007-10-26 2009-04-30 (주)아모레퍼시픽 Method for preparing chrysanthemum green tea
KR20100033573A (en) * 2008-09-22 2010-03-31 성균관대학교산학협력단 The composition for anti-oxidation or anti-inflammation comprising chrysanthemum extract and the method of preparation thereof
KR20170100076A (en) 2016-02-24 2017-09-04 신성대학 산학협력단 Cosmetic composition comprising aged chrysanthemum

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
EL-Domyati M et.al., Exp Dermatololl, 2002
korean J. plant Res., 23(1):47, 2010
Serafin, WE, In Goodman and Gillmans, The Pharmacological Basis of Therapeutics, Hardmen, Ja; Limbird, L,E eds, Mc Graw-Hill, Newyork, 1996, 659-682
Townley RG & 0kada, C, Annals of Allergy, 68, 1991, 190-196

Also Published As

Publication number Publication date
KR102242755B1 (en) 2021-04-20

Similar Documents

Publication Publication Date Title
KR101504908B1 (en) Compositions for enhancing skin barrier comprising extract of Boehmeria nivea
US11484559B2 (en) Kapok tree flower extract, and cosmetic, pharmaceutical or dermatological compositions containing same
KR100986249B1 (en) Natural antimicrobial and antiseptic substance made from Dryopteris crassirhizoma root extract complex
KR102099783B1 (en) Cosmetic Composition Containing The Mixed Extract of Dracaena fragrans and Trifolium repens
KR101619571B1 (en) Anti-aging Composition for Skin External Application Comprising Magnolia Placenta Culture Extracts
KR102242755B1 (en) Cosmetic composition for anti-inflametion, anti-wrinkle, whitening and anti-bacterial comprising Extract of Chrysanthemum morifolium
KR101837020B1 (en) Separation method for saponins from Sapindus mukorossi and cosmetic composition containing the same
KR102303644B1 (en) Face cosmetics fermentation composition comprising vegetable mixed extract and tumeric extract
KR102226179B1 (en) Cosmetic Compositions for Anti-aging Comprising Extracts of Plants
KR101974502B1 (en) Cosmetic composition for anti-allergy and for improving atopic dermatitis comprising extract of anemone reflexa stephan as active ingredient
KR102539209B1 (en) Cosmetic composition for skin-whitening, anti-oxidant, anti-inflammatory, skin anti-irritation and moisturizing comprising the extract of Nymphaea alba, Backhousia citriodora and Malus pumila
KR20190036388A (en) Cosmetic composition with extract of Nypa fruticans Wurmb. Fruit
WO2020203933A1 (en) Antiaging agent, antioxidant, antiinflammatory agent and whitening agent, and cosmetic
KR101207560B1 (en) Cosmetic composition comprising the extract of Cleyera japonica as active ingredient
KR20170137560A (en) Composition for improving skin condition comprising herb extracts mixture
KR20170137559A (en) Composition for improving skin condition comprising herb extracts mixture
KR20150090014A (en) Anti-aging Composition for Skin External Application Comprising Liriodendron tulipifera Placenta Culture Extracts
KR102504878B1 (en) cosmetic composition having anti-inflammatory and skin soothing and effects and improvement of skin itching containing fermented extracts of Campsis grandiflora, Plum blossom, Quercus acuta THUNB
KR101619711B1 (en) Anti-aging Composition for Skin External Application Comprising Schizandra chinensis Placenta Culture Extracts
KR102376616B1 (en) Mugwort fermentation product and a manufacturing method for improving the active ingredient content of the mugwort fermentation produced therefrom, and a cosmetic composition comprising a composition and fermented product effective in improving skin wrinkles and anti-aging containing the same as an active ingredient
KR102053731B1 (en) A cosmetic composition for skin tenperature control comprising spirulina extract and methods
KR102514212B1 (en) Cosmetic composition and method for preparing the same
EP2512495B1 (en) Process for obtaining a standardised extract of quercetin an 3-o-methylquercetin from flowers of macela (achyrocline satureioides), and cosmetic and pharmaceutical compositions comprising said extract
KR101107614B1 (en) Cosmetic Composition Containing Fermented of Viola mandshurica Extract
KR102115831B1 (en) Method of manufacturing functional cosmetics for scalp using pussy willow extract

Legal Events

Date Code Title Description
E701 Decision to grant or registration of patent right
GRNT Written decision to grant